| Revenue | NOK 0 | — |
| EBITDA | NOK -15K | +37% |
| Net profit | NOK -15K | +37% |
| Total assets | NOK 5 | -100% |
| Equity | NOK -11K | -396% |
| Employees | 0 | — |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | −326 | −0 | −157 | −138 | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −334 | −10 | −175 | −264 | −13 | −14 | −14 | −24 | −15 |
| Depreciation & amort. | −0 | −5 | −26 | −41 | −36 | −15 | −0 | −0 | −0 |
| EBIT | −334 | −16 | −201 | −305 | −49 | −29 | −14 | −24 | −15 |
| Net financials | −1 | −8 | −14 | −21 | −12 | 0 | 0 | 0 | 0 |
| Profit before tax | −335 | −24 | −215 | −326 | −61 | −29 | −14 | −24 | −15 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | −335 | −24 | −215 | −326 | −61 | −29 | −14 | −24 | −15 |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Total assets | 86 | 96 | 98 | 960 | 32 | 4 | 0 | 42 | 0 |
| Equity | −244 | −268 | −483 | 91 | 29 | 1 | −13 | 4 | −11 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 330 | 365 | 581 | 870 | 2 | 4 | 13 | 38 | 11 |
| Total debt | 330 | 365 | 581 | 870 | 2 | 4 | 13 | 38 | 11 |
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2021 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2017 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Deepx Health As | Company | 100.0% | 100.0% | 2022 |
| Person | Role here | Other companies |
|---|---|---|
| Hans Johan Hekland | Chairman | 0 companies |
| Christian Horn | Board of Directors | 0 companies |
| Øivind Enger | Board of Directors | 0 companies |